These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38317470)

  • 1. Solid Lipid Nanoparticles as an Innovative Lipidic Drug Delivery System.
    Waghmare S; Palekar R; Potey L; Khedekar P; Sabale P; Sabale V
    Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38317470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages.
    Ghasemiyeh P; Mohammadi-Samani S
    Res Pharm Sci; 2018 Aug; 13(4):288-303. PubMed ID: 30065762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment.
    Graván P; Aguilera-Garrido A; Marchal JA; Navarro-Marchal SA; Galisteo-González F
    Adv Colloid Interface Sci; 2023 Apr; 314():102871. PubMed ID: 36958181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles: a review on recent perspectives and patents.
    Paliwal R; Paliwal SR; Kenwat R; Kurmi BD; Sahu MK
    Expert Opin Ther Pat; 2020 Mar; 30(3):179-194. PubMed ID: 32003260
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral delivery of solid lipid nanoparticles: underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate.
    Mahmoudian M; Maleki Dizaj S; Salatin S; Löbenberg R; Saadat M; Islambulchilar Z; Valizadeh H; Zakeri-Milani P
    Expert Opin Drug Deliv; 2021 Nov; 18(11):1707-1722. PubMed ID: 34553650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.
    Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
    Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
    Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
    Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances and patents on solid lipid nanoparticles.
    Sawant KK; Dodiya SS
    Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems.
    Mishra V; Bansal KK; Verma A; Yadav N; Thakur S; Sudhakar K; Rosenholm JM
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30340327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid Lipid Nanoparticles (SLNs): Advancements in Modification Strategies Toward Drug Delivery Vehicle.
    Al-Sayadi GMH; Verma A; Choudhary Y; Sandal P; Patel P; Singh D; Gupta GD; Kurmi BD
    Pharm Nanotechnol; 2023; 11(2):138-154. PubMed ID: 36305142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles: a modern formulation approach in drug delivery system.
    Mukherjee S; Ray S; Thakur RS
    Indian J Pharm Sci; 2009 Jul; 71(4):349-58. PubMed ID: 20502539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 13. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration.
    Fonseca-Santos B; Silva PB; Rigon RB; Sato MR; Chorilli M
    Curr Med Chem; 2020; 27(22):3623-3656. PubMed ID: 31232233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid nanoparticles as drug delivery systems.
    Manjunath K; Reddy JS; Venkateswarlu V
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage Form Perspectives, and Translational Status.
    Liu M; Wen J; Sharma M
    Curr Pharm Des; 2020; 26(27):3203-3217. PubMed ID: 32452322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review.
    Haider M; Abdin SM; Kamal L; Orive G
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32210127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems.
    Danaei M; Dehghankhold M; Ataei S; Hasanzadeh Davarani F; Javanmard R; Dokhani A; Khorasani S; Mozafari MR
    Pharmaceutics; 2018 May; 10(2):. PubMed ID: 29783687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review.
    Gunawan M; Boonkanokwong V
    Colloids Surf B Biointerfaces; 2024 Jan; 233():113608. PubMed ID: 37925866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanocarriers in drug delivery: characterization and design.
    Mu H; Holm R
    Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and tailoring of hybrid lipid nanocarriers.
    Islan GA; Cacicedo ML; Rodenak-Kladniew B; Duran N; Castro GR
    Curr Pharm Des; 2017 Nov; ():. PubMed ID: 29141536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.